News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
372,323 Results
Type
Article (22789)
Company Profile (30)
Press Release (349503)
Multimedia
Podcasts (107)
Webinars (12)
Section
Business (118462)
Career Advice (1413)
Deals (17211)
Drug Delivery (64)
Drug Development (41916)
Employer Resources (95)
FDA (8699)
Job Trends (8340)
News (188938)
Policy (16981)
Tag
Academia (1442)
Academic (1)
Accelerated approval (11)
Adcomms (13)
Allergies (77)
Alliances (33054)
ALS (100)
Alzheimer's disease (950)
Antibody-drug conjugate (ADC) (157)
Approvals (8878)
Artificial intelligence (307)
Autoimmune disease (73)
Automation (25)
Bankruptcy (157)
Best Places to Work (6959)
BIOSECURE Act (6)
Biosimilars (104)
Biotechnology (24)
Bladder cancer (102)
Brain cancer (28)
Breast cancer (368)
Cancer (2856)
Cardiovascular disease (239)
Career advice (1216)
Career pathing (28)
CAR-T (137)
CDC (23)
Cell therapy (429)
Cervical cancer (22)
Clinical research (35928)
Collaboration (1088)
Company closure (1)
Compensation (247)
Complete response letters (20)
COVID-19 (1477)
CRISPR (57)
C-suite (364)
Cystic fibrosis (77)
Data (3882)
Decentralized trials (2)
Denatured (36)
Depression (68)
Diabetes (310)
Diagnostics (3503)
Digital health (25)
Diversity (6)
Diversity, equity & inclusion (29)
Drug discovery (143)
Drug pricing (87)
Drug shortages (20)
Duchenne muscular dystrophy (134)
Earnings (57338)
Editorial (38)
Employer branding (12)
Employer resources (83)
Events (56600)
Executive appointments (519)
FDA (10469)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (2)
Frontotemporal dementia (15)
Funding (749)
Gene editing (117)
Generative AI (33)
Gene therapy (370)
GLP-1 (561)
Government (2326)
Grass and pollen (6)
Guidances (316)
Healthcare (10156)
HIV (38)
Huntington's disease (25)
IgA nephropathy (51)
Immunology and inflammation (136)
Immuno-oncology (21)
Indications (58)
Infectious disease (1603)
Inflammatory bowel disease (117)
Inflation Reduction Act (11)
Influenza (54)
Intellectual property (130)
Interviews (264)
IPO (8322)
IRA (30)
Job creations (1704)
Job search strategy (992)
Kidney cancer (7)
Labor market (45)
Layoffs (248)
Leadership (27)
Legal (4372)
Liver cancer (41)
Longevity (8)
Lung cancer (410)
Lymphoma (248)
Machine learning (20)
Management (32)
Manufacturing (405)
MASH (110)
Medical device (6704)
Medtech (6725)
Mergers & acquisitions (9511)
Metabolic disorders (739)
Multiple sclerosis (96)
NASH (9)
Neurodegenerative disease (164)
Neuropsychiatric disorders (40)
Neuroscience (1598)
NextGen: Class of 2025 (3366)
Non-profit (2674)
Now hiring (7)
Obesity (314)
Opinion (188)
Ovarian cancer (80)
Pain (99)
Pancreatic cancer (113)
Parkinson's disease (145)
Partnered (17)
Patents (257)
Patient recruitment (191)
Peanut (26)
People (27762)
Pharmaceutical (9)
Pharmacy benefit managers (14)
Phase I (10753)
Phase II (15259)
Phase III (12857)
Pipeline (2853)
Policy (149)
Postmarket research (1631)
Preclinical (4758)
Press Release (31)
Prostate cancer (180)
Psychedelics (23)
Radiopharmaceuticals (153)
Rare diseases (449)
Real estate (2543)
Recruiting (37)
Regulatory (12526)
Reports (20)
Research institute (1347)
Resumes & cover letters (215)
Rett syndrome (15)
RNA editing (8)
RSV (40)
Schizophrenia (87)
Series A (132)
Series B (85)
Service/supplier (3)
Sickle cell disease (63)
Special edition (12)
Spinal muscular atrophy (73)
Sponsored (26)
Startups (1490)
State (1)
Stomach cancer (10)
Supply chain (49)
Tariffs (36)
The Weekly (70)
Vaccines (551)
Venture capital (35)
Weight loss (202)
Women's health (41)
Worklife (13)
Date
Last 7 days (431)
Last 30 days (1521)
Last 365 days (18929)
2025 (18463)
2024 (20137)
2023 (22145)
2022 (27996)
2021 (29791)
2020 (29081)
2019 (24989)
2018 (18476)
2017 (17408)
2016 (16947)
2015 (19291)
2014 (16211)
2013 (14179)
2012 (13984)
2011 (13417)
2010 (12661)
Location
Africa (541)
Alabama (56)
Alaska (4)
Arizona (116)
Arkansas (7)
Asia (21648)
Australia (3554)
California (5995)
Canada (1868)
China (581)
Colorado (277)
Connecticut (309)
Delaware (194)
Europe (51142)
Florida (1001)
Georgia (210)
Idaho (23)
Illinois (441)
India (37)
Indiana (339)
Iowa (9)
Japan (250)
Kansas (72)
Kentucky (15)
Louisiana (8)
Maine (30)
Maryland (778)
Massachusetts (4467)
Michigan (185)
Minnesota (276)
Mississippi (1)
Missouri (49)
Montana (11)
Nebraska (9)
Nevada (71)
New Hampshire (30)
New Jersey (1968)
New Mexico (13)
New York (1742)
North Carolina (836)
North Dakota (5)
Northern California (2849)
Ohio (154)
Oklahoma (14)
Oregon (19)
Pennsylvania (1319)
Puerto Rico (4)
Rhode Island (24)
South America (743)
South Carolina (26)
Southern California (2407)
Tennessee (109)
Texas (918)
United States (22260)
Utah (199)
Vermont (1)
Virginia (128)
Washington D.C. (52)
Washington State (496)
West Virginia (2)
Wisconsin (52)
Wyoming (2)
372,323 Results for "bausch and lomb".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch + Lomb Announces Third-Quarter 2025 Results
October 29, 2025
·
19 min read
Press Releases
Bausch + Lomb Announces Board Changes - August 18, 2025
August 18, 2025
·
1 min read
Press Releases
Bausch + Lomb to Participate in Upcoming September 2025 Investor Conferences
August 15, 2025
·
1 min read
Press Releases
Bausch + Lomb Announces Second-Quarter 2025 Results
July 30, 2025
·
19 min read
Press Releases
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
September 30, 2025
·
1 min read
Press Releases
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers
September 9, 2025
·
5 min read
Press Releases
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
September 11, 2025
·
6 min read
Press Releases
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops
July 30, 2025
·
4 min read
Press Releases
Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference
May 22, 2025
·
1 min read
Press Releases
Bausch + Lomb Announces First-Quarter 2025 Results
April 30, 2025
·
19 min read
1 of 37,233
Next
